Form EFFECT GT Biopharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 20, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- On National Apple Day, Vincent Renovatio™ Launches "An Apple A Day" at Walmart Aussie Apple Doc, Vincent Candrawinata, Reveals Secrets about the Apple
- AINewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Featured in AINewsWire Editorial on Shift Toward Preventive, AI-Enabled Healthcare
- U.S. Cyber Command selects Leidos for full-spectrum cyber operations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share